• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Novavax Could Surprise on the Upside - No Bearish Divergences Yet

Let's review the charts and indicators.
By BRUCE KAMICH
Jul 06, 2020 | 02:40 PM EDT
Stocks quotes in this article: INO, NVAX

Don't turn big profits into big losses, Jim Cramer told viewers of Mad Money Thursday night. When you've got big gains in a speculative stock, count your blessings and sell. Cramer said it's time to ring the register on two early-stage biotechs, Novavax (NVAX) and Inovio Pharmaceuticals (INO) , two companies working on a Covid-19 vaccine.

 
This is sound advice but I looked at the charts of NVAX today to see if there were technical reasons to become a seller. 
 
In this daily Japanese candlestick chart of NVAX, below, we can see just two upper shadows at the end of June. There is a doji at the beginning of July but it lacks bearish confirmation. I do not see a pattern of 8 to 10 record highs to tell me that prices are extended and vulnerable to a reversal.
 
The On-Balance-Volume (OBV) line has risen nicely with the price action and does not show a bearish divergence. The moving averages that we favor have positive slopes and the Moving Average Convergence Divergence (MACD) oscillator has narrowed but not crossed to the downside for a take profits signal. 
 
 
 
In this weekly Japanese candlestick chart of NVAX, below, we do see a doji pattern telling us there is a balance between bulls and bears as the opening and closing was the same. The next weekly candlestick pattern needs to confirm this as a reversal with a bearish candle. That might not happen and we could see the uptrend being "refreshed".
 
The weekly OBV line is bullish and so is the MACD oscillator. 
 
 
 
In this Point and Figure chart of NVAX, below, we used daily price data. The software is reading the X's and O's as accumulation (buying) and generated a potential upside price target in the $172 area. This price target is in no way guaranteed but a downside price target would give me poise about going long. A trade at $70.15 would weaken this chart. 
 
 
Bottom line strategy: NVAX may indeed be speculative but at this juncture in time I find no glaring reasons to be a seller. That could change at any time. Longs should risk a close below $70
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Biotechnology | Healthcare | Mad Money | Coronavirus

More from Investing

AMC Is a High Risk, High Reward Play

Timothy Collins
Jan 22, 2021 2:15 PM EST

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

Bruce Kamich
Jan 22, 2021 2:03 PM EST

IPOs in recent months have done extremely well -- not so GDRX.

2021 and 2022 Look Difficult for Intel, While 2023 -- Might -- Be Better

Eric Jhonsa
Jan 22, 2021 1:44 PM EST

Competition from AMD and ARM CPU developers looks set to take a toll over the next two years. But Intel could be in better shape in 2023 if its new CEO is ready to make some tough choices.

GameStop and the Dangerous Game of Gamma Squeezes

Timothy Collins
Jan 22, 2021 1:26 PM EST

What happened after Citron Research posted a video about GameStop is very troubling.

Stocks Are Well Off Early Lows, but There's Still Quite a Bit of Weakness

James "Rev Shark" DePorre
Jan 22, 2021 1:18 PM EST

There is still strong interest in stock picking which is the most positive thing about this market.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I'll discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login